Inducing tumor ferroptosis via a pH-responsive NIR-II photothermal agent initiating lysosomal dysfunction

Zhiwei Zhang1,2,3, Jingjing Xiang2,3, Lijiao Guan1

  • 1Northwest University, Xi'an 710069, China. huangsaipeng@nwu.edu.cn.

Nanoscale
|November 27, 2023
PubMed

Insights

This study introduces IR-PE, a pH-activated photothermal sensitizer that triggers ferroptosis (a programmed cell death) via Fenton chemistry. This approach enhances tumor treatment efficacy while minimizing side effects.

Area of Science:

  • Biomedical Engineering
  • Cancer Biology
  • Nanotechnology

Background:

  • Ferroptosis is a critical programmed cell death pathway in tumor biology and treatment.
  • Modulating tumor ferroptosis using cell-intrinsic Fenton chemistry remains a significant challenge.
  • Spatiotemporal control over Fenton chemistry is key for effective cancer therapy.

Purpose of the Study:

  • To design and synthesize a novel pH-activated photothermal sensitizer for targeted ferroptosis induction.
  • To investigate the mechanism of IR-PE in triggering lysosomal dysfunction-mediated Fenton chemistry.
  • To evaluate the efficacy of IR-PE in improving antitumor effects and reducing systemic toxicity.

Main Methods:

  • Synthesis of a cyanine-based photothermal sensitizer (IR-PE) with a diamine moiety.
  • Utilizing near-infrared light irradiation to activate the photothermal sensitizer.
  • Investigating the induction of lysosomal dysfunction and subsequent Fenton pathway activation.
  • Assessing ferroptosis induction and antitumor efficacy in relevant models.

Main Results:

  • Successfully designed and synthesized the pH-activated photothermal sensitizer IR-PE.
  • IR-PE effectively triggered lysosomal dysfunction and the Fenton pathway under near-infrared irradiation.
  • The treatment evoked ferroptosis, leading to improved antitumor efficacy.
  • Systemic side effects were significantly mitigated compared to conventional approaches.

Conclusions:

  • The developed IR-PE sensitizer offers a novel strategy for spatiotemporally controlled ferroptosis induction.
  • pH-activated photothermal therapy holds promise for targeted cancer treatment by modulating ferroptosis.
  • This approach enhances therapeutic outcomes while minimizing off-target toxicity.